Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
about
Clinical significance of hepatitis C virus genotypesExposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strainThyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveProspective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapyInterferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutationsNucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liverNatural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry siteGenetic Clustering of Hepatitis C Virus Strains and Severity of Recurrent Hepatitis after Liver TransplantationHepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1bComparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma.Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.Managing Occupational Risks for Hepatitis C Transmission in the Health Care SettingIdentification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 ProteinSerum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological featuresClinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos studyInterferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtypeHepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patientsHepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcomeGenotyping of hepatitis C virus isolates from Basque Country, SpainAccurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technologySecond-generation line probe assay for hepatitis C virus genotypingGenotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR methodComparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patientsComparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution methodSerological determination of hepatitis C virus genotype: comparison with a standardized genotyping assayDetermination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysisFrequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmissionHepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experiencesiRNAs: potential therapeutic agents against hepatitis C virusLongitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-αClinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease.Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish populationIncreased mortality from liver cancer in England and Wales is not related to hepatitis C.Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus InfectionPrediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection.Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of PakistanHepatocellular carcinoma in the world and the middle East.Clinical sequelae of hepatitis C acquired from injection drug use.Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis CHepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan.
P2860
Q24514512-100DC5BC-BEEB-4B21-839B-B642C4B01A6BQ24529494-DFCFF6C3-CFD5-4E27-81B4-D827FE195EC2Q26827517-51CA067C-0E94-4894-ACF0-80A0AFEB0C55Q27469310-196846EE-AE6D-41CA-8351-AEB92B831DC9Q27469554-7C332D93-E8C2-4AE4-9AF8-F146999791B3Q27469624-C2AFA166-8C64-40C3-A612-BFA41EDF6EB4Q27469708-F6969ED7-76F7-4130-908C-C77001AFFA65Q27469882-69BF0562-A8C4-471D-A969-4EF6A65C2058Q27472749-14EDC9FC-D166-479E-BA83-D42C6E382388Q27472753-53D59011-B076-44B9-AC70-68369D4DC97AQ27473018-9FEE24B0-CB27-493A-943C-A1574F77170CQ27477626-1775BD32-2DA0-414D-BFA2-431B97EB5099Q27477675-3A4F04D2-C0C5-479D-9D20-43AB62573108Q27477831-DC8FF2A8-A80E-4684-A7A2-0ACD3A3AEF83Q27477835-E643AC06-B628-436B-83DB-8136A900CA49Q27477854-6E9EEED9-F162-42E3-A623-179565AE187EQ27477975-545DE73A-AD44-4711-8BCD-00CCA56595A8Q27477979-657BCD21-D086-4119-8C4C-84D89A5586A5Q27485608-646E5708-0E71-4AF2-A4B9-EB8634FEA537Q27485690-976220C7-D01F-4E00-B999-11A7C84BABBCQ27485722-6090F507-C5C0-4F6F-802D-FA4B02D6140FQ27485737-FE4FD473-8034-4315-A009-0E70AF981777Q27485751-DB5DF815-27F3-403C-9547-F502184B4410Q27485773-3F639516-D133-4712-87DA-629289241F42Q27485780-8541744E-A118-41B9-BD3D-9F3FEBF513F0Q27485824-DAC04DB7-B08F-4317-A77E-7098800AFDE3Q27486226-937E64A2-4A0F-4471-85D3-E6D4438C6182Q27490250-4E322289-4C12-42DE-B003-99E2D67829BAQ27694682-4B96E6EC-10A6-4940-A575-A8D388615737Q28483978-BA6F52AD-BD32-462E-BD35-4682F6B32E97Q33495598-284EABAE-5843-4FDF-9A9F-AC03CE16BB56Q33617717-31CE69C6-82B3-440A-8AB0-7B127D704606Q33797399-8695248E-0738-4DA4-81A3-759A621B05D5Q33826256-DAEF550E-EF69-47FB-BF20-747E4BF40F0CQ34098886-9FD36FE2-BD14-4018-91CC-35772F9D5727Q34114168-EAF9A6C4-08CB-47EC-AE80-3B7E1111A333Q34134967-C77D2B6F-A8E3-4C45-8E72-F3561DE31E17Q34183346-C432FFE6-123F-455F-AC72-85E11E5A2D71Q34225261-7937F484-3457-406E-B50C-3588364CB112Q34522014-7FE956AD-4681-4013-9876-EBA731814BE0
P2860
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
@en
Hepatitis C virus type 1b
@nl
type
label
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
@en
Hepatitis C virus type 1b
@nl
prefLabel
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
@en
Hepatitis C virus type 1b
@nl
P2093
P1476
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
@en
P2093
P304
P356
10.7326/0003-4819-122-3-199502010-00001
P407
P577
1995-02-01T00:00:00Z